Used in neuroscience and biomedical research to quantify glial fibrillary acidic protein (GFAP) levels in monkey samples, this ELISA kit helps assess astrocyte activation and neuroinflammation. It is commonly applied in studies of traumatic brain injury, neurodegenerative diseases such as Alzheimer's, and central nervous system disorders. The kit enables researchers to monitor disease progression, evaluate therapeutic interventions, and investigate blood-brain barrier integrity by providing a sensitive and specific measurement of GFAP, a key biomarker for astroglial damage. Widely used in preclinical studies involving non-human primates, it supports translational research aiming to bridge findings from animal models to human neurological conditions.